Matthew A. Gubens MD, MS

Matthew A. Gubens, MD, MS, is Associate Professor of Medicine in the Division of Hematology/Oncology at the University of California, San Francisco (UCSF). He also is a treating physician and serves as Medical Director of the Thoracic Medical Oncology Clinic at the UCSF Helen Diller Family Comprehensive Cancer Center. He serves as Co-Chair of the Thoracic Oncology Site Committee, which oversees thoracic clinical trials at UCSF. He also serves as Vice Chair of the UCSF Cancer Center-wide Protocol Review and Monitoring Committee.

Dr. Gubens earned a medical degree at Stanford University School of Medicine and completed an internal medicine residency at UCSF Medical Center, followed by a medical oncology fellowship at Stanford University. He also earned a master of science degree at the Harvard School of Public Health.

Dr. Gubens specializes in the treatment of non-small cell lung cancer, small cell lung cancer, thymoma and thymic carcinoma, and mesothelioma. His research involves designing clinical trials to study novel compounds and therapeutic strategies in lung cancer, especially in immunotherapy and molecularly targeted therapies. He and his colleagues have a special interest in translational medicine and are actively working to translate laboratory-based findings to the clinic.

Dr. Gubens is a member of several professional organizations, including the American Society of Clinical Oncology, the International Association for the Study of Lung Cancer, the International Thymic Malignancy Interest Group, and the Society for Immunotherapy of Cancer.

Dr. Gubens also is a member of the NCCN Non-Small Cell Lung Cancer/Malignant Pleural Mesothelioma/Thymomas and Thymic Carcinomas Panel.